HighGravityDataMicrochip Technology — Aug 6, 2026 release
Fiscal 2027 first-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000827054-26-000037
Showing in the filing
Capital expenditures
“between $20 million and $25 million”
Period
FY2026
Measure
Company-defined measure
Source
Prose
All guidance in this release · 36
Net sales for the September quarter
“up sequentially between 7% and 9%”
Net sales sequential growth
“up sequentially between 7% and 9%”
Net sales year-over-year growth (at midpoint)
“approximately 40.6%”
Quarterly dividend on common stock
“45.5 cents per share”
Quarterly dividend on Series A Mandatory Con… for FY2026
“$18.750 per share (which represents $0.9375 per depositary share)”
Quarterly cash dividend on Microchip's 7.50%…
“$18.750 per share”
Net Sales for Q2 FY2027
“$1.589 to $1.618 billion”
Gross Profit - GAAP for Q2 FY2027
“65.4% to 66.3%”
Gross Profit - Non-GAAP Adjustments for Q2 FY2027
“$10.3 to $11.3 million”
Gross Profit - Non-GAAP for Q2 FY2027
“66.0% to 67.0%”
Operating Expenses - GAAP for Q2 FY2027
“37.3% to 37.4%”
Operating Expenses - Non-GAAP Adjustments for Q2 FY2027
“$155.7 to $159.7 million”
Operating Expenses - Non-GAAP for Q2 FY2027
“27.5%”
Operating Income - GAAP for Q2 FY2027
“28.1% to 28.9%”
Operating Income - Non-GAAP Adjustments for Q2 FY2027
“$166.0 to $171.0 million”
Operating Income - Non-GAAP for Q2 FY2027
“38.5% to 39.5%”
Other Expense, net - GAAP for Q2 FY2027
“$48.7 to $49.3 million”
Other Expense, net - Non-GAAP Adjustments for Q2 FY2027
“$(0.2) to $0.2 million”
Other Expense, net - Non-GAAP for Q2 FY2027
“$48.5 to $49.5 million”
Income Tax Provision - GAAP for Q2 FY2027
“$75.3 to $96.5 million”
Income Tax Provision - Non-GAAP Adjustments for Q2 FY2027
“$(52.2) to $(33.1) million”
Income Tax Provision - Non-GAAP for Q2 FY2027
“$42.2 to $44.3 million”
Net income - GAAP for Q2 FY2027
“$321.0 to $323.0 million”
Net income - Non-GAAP Adjustments for Q2 FY2027
“$199.0 to $223.4 million”
Dividends on Series A Preferred Stock - Non-… for Q2 FY2027
“$27.8 million”
Net income attributable to common stockholde… for Q2 FY2027
“$293.2 to $295.2 million”
Net income attributable to common stockholde… for Q2 FY2027
“$226.8 to $251.2 million”
Net income attributable to common stockholde… for Q2 FY2027
“$520.0 to $546.4 million”
Diluted Common Shares Outstanding - GAAP for Q2 FY2027
“Approximately 550.7 to 551.7 million shares”
Diluted Common Shares Outstanding - Non-GAAP… for Q2 FY2027
“23.8 million shares”
Diluted Common Shares Outstanding - Non-GAAP for Q2 FY2027
“Approximately 574.5 to 575.5 million shares”
Diluted net income per common share - GAAP for Q2 FY2027
“$0.53 to $0.54”
Diluted net income per common share - Non-GA… for Q2 FY2027
“$0.38 to $0.41”
Diluted net income per common share - Non-GAAP for Q2 FY2027
“$0.91 to $0.95”
Capital expenditures for FY2026
“between $20 million and $25 million”
Capital expenditures for FY2027
“approximately $100 million”
Exhibit 99.1 · the passage around this item
… earlier in the release
(5) Our GAAP guidance excludes the impact of any potential gains or charges related to our ongoing evaluation of restructuring activities including the sale of our Fab 2 wafer fabrication facility in Tempe, Arizona. Capital expenditures for the quarter ending September 30, 2026 are expected to be between $20 million and $25 million. Capital expenditures for all of fiscal 2027 are expected to be approximately $100 million. Consistent with the slow macroeconomic environment in fiscal 2025, we have paused most of our factory expansion actions and reduced our planned capital investments through fiscal 2027. However, we are adding capital equipment to selectively expand our production capacity and add research and development equipment. Under the GAAP revenue recognition standard, we are required to recognize revenue when control of the product changes from us to a customer or distributor. We focus our sales and marketing efforts on creating demand for our products in the end markets we serve and not on moving inventory into our distribution network. We also manage our manufacturing and supply chain operations, including our distributor relationships, towards the goal of having our products available at the time and location the end customer desires. - - more - - Microchip Technology Reports First Quarter Fiscal 2027 Financial Results Page 5 Use of Non-GAAP Financial Measures: Our non-GAAP adjustments, where applicable, include the effect of share-based compensation, restructuring charges, expenses related to our
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.